Results 131 to 140 of about 21,395 (260)

Hyperphosphatemia due to erdafitinib (a pan-FGFR Inhibitor) and anti-tumour activity among patients (Pts) with advanced urothelial carcinoma (UC)

open access: bronze, 2019
S.T. Tagawa   +9 more
openalex   +1 more source

High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression [PDF]

open access: yes, 2010
In chronic kidney disease, hyperphosphatemia has been associated to vascular calcifications. Moreover, the rate and progression of vascular calcification have been related with the reduction of bone mass and osteoporotic fractures, hereby suggesting a ...
Cannata, J.B. (Jorge)   +5 more
core  

Update on tumor lysis syndrome management

open access: yesJournal of Health Science and Medical Research (JHSMR), 2006
Tumor lysis syndrome (TLS) is an oncologic emergency resulting from rapid cancer cell destruction as a result of spontaneous tumor necrosis or treatment-related cell lysis.
P Angsuwatcharakon, P Sunpaweravong
doaj  

Studies of the Various Chronic Kidney Failure Rat Models and Hemodialysis Mini-pig Model for the Evaluation of Anti-hyperphosphatemia Drugs

open access: diamond, 2019
Tomoyuki Okabe   +6 more
openalex   +2 more sources

Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients [PDF]

open access: gold, 2019
Hongran Moon   +6 more
openalex   +1 more source

Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD [PDF]

open access: bronze, 2014
Keitaro Yokoyama   +7 more
openalex   +1 more source

Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)2D and normal FGF7 concentrations characterize patients with CKD [PDF]

open access: gold, 2021
Kittrawee Kritmetapak   +7 more
openalex   +1 more source

Severe Systemic Calciphylaxis in a Young Cat [PDF]

open access: yes
Brandenburg   +24 more
core   +1 more source

Home - About - Disclaimer - Privacy